Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Stress Ball and Empathic Verbal-Tactile Interventions for Reducing Anxiety and Pain in Mammography and Breast Ultrasonography: A Randomized Trial

25 april 2026 bijgewerkt door: Betül Güven, Istanbul University

Effects of Stress Ball Use and Empathic Verbal Communication With Therapeutic Touch on Anxiety and Pain Perception in Women Undergoing Mammography and Breast Ultrasonography: A Randomized Controlled Trial

This prospective, randomized controlled trial aims to determine the effects of stress ball use and empathic verbal communication with therapeutic touch on anxiety and pain perception in women undergoing mammography and breast ultrasonography. The study will be conducted between May and September 2026 at Istanbul Bakırköy Dr. Sadi Konuk Training and Research Hospital.

A total of 122 women meeting the inclusion criteria will be randomly assigned into three groups: stress ball group (n=41), empathic verbal communication with touch group (n=41), and control group (n=40). Women in the stress ball group will be instructed to use a soft stress ball before and during the procedure. Participants in the empathic verbal-tactile group will receive structured verbal empathy combined with therapeutic touch. The control group will receive routine care without additional intervention.

Data will be collected before and after the procedures using a Descriptive Characteristics Form, the State-Trait Anxiety Inventory, and a Numerical Rating Scale for pain assessment. The findings of this study are expected to provide evidence on the effectiveness of non-pharmacological interventions in reducing anxiety and pain during breast imaging procedures.

Studie Overzicht

Gedetailleerde beschrijving

This study is designed as a prospective, parallel-group randomized controlled trial to examine the effects of stress ball use and empathic verbal communication combined with therapeutic touch on anxiety levels and pain perception in women undergoing mammography and breast ultrasonography. The research will be carried out between May and September 2026 at Istanbul Bakırköy Dr. Sadi Konuk Training and Research Hospital.

Prior to participant recruitment, all necessary ethical approvals will be secured. Eligible women presenting for mammography and breast ultrasonography will be informed about the study purpose, procedures, and voluntary nature of participation, and written informed consent will be obtained. Inclusion criteria consist of being 18 years of age or older, undergoing these imaging procedures for the first time, being literate, and having no sensory or motor impairment affecting the upper extremities. Women with previous experience of these procedures, as well as those with cognitive, physical, visual, or hearing impairments, will be excluded.

The sample size was determined as 122 participants based on a 95% confidence level and 5% margin of error. Participants will be allocated into three groups in a 1:1:1 ratio: stress ball group (n=41), empathic verbal communication with therapeutic touch group (n=41), and control group (n=40).

Randomization and Allocation Procedure Participants will be randomized individually on the day of their scheduled mammography and breast ultrasonography appointments. After confirming eligibility and obtaining written informed consent, participants will be assigned to one of three groups (stress ball, empathic verbal communication with therapeutic touch, or control) using a computer-generated randomization sequence.

Block randomization with a 1:1:1 allocation ratio will be used to ensure balanced group sizes throughout the study period. The randomization list will be prepared in advance by an independent researcher who is not involved in recruitment, intervention delivery, or data collection.

To maintain allocation concealment, group assignments will be placed in sequentially numbered, opaque, sealed envelopes. These envelopes will be opened only after participant enrollment, in the order of inclusion.

Randomization will be implemented continuously on a daily basis as participants present for their scheduled appointments, ensuring that group assignment remains unpredictable and independent of appointment timing.

Due to the nature of the interventions, blinding of participants and intervention providers is not feasible. However, outcome data will be collected using standardized and validated self-report instruments to minimize bias.

Intervention Procedures Participants assigned to the stress ball group will be provided with a soft, smooth stress ball (6 cm in diameter) and instructed to repeatedly squeeze and relax it while waiting for the procedure and during ultrasonography.

Participants in the empathic verbal communication with therapeutic touch group will be taken to a quiet waiting area. Trained researchers will use predefined empathic statements and simultaneously apply gentle touch by placing a hand on the participant's shoulder.

Participants in the control group will receive routine clinical care without any additional intervention.

Data Collection and Outcomes Data will be collected immediately before and after the imaging procedures. A Descriptive Characteristics Form will be used to obtain sociodemographic and clinical information. Anxiety levels will be assessed using the State-Trait Anxiety Inventory (STAI), and pain intensity will be measured using a Numerical Rating Scale ranging from 0 (no pain) to 10 (worst possible pain).

The primary aim of the study is to evaluate the effectiveness of these non-pharmacological interventions in reducing anxiety and perceived pain during breast imaging procedures.

Data Analysis Statistical analyses will be conducted using statistical software. Descriptive statistics will summarize baseline characteristics. Between-group differences in anxiety and pain scores will be assessed using appropriate tests based on data distribution (e.g., one-way ANOVA or Kruskal-Wallis test), while within-group changes will be analyzed using paired comparisons. Post hoc analyses will be performed where applicable. Statistical significance will be set at p < 0.05.

Studietype

Ingrijpend

Inschrijving (Geschat)

122

Fase

  • Niet toepasbaar

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Volwassen
  • Oudere volwassene

Accepteert gezonde vrijwilligers

Ja

Beschrijving

Inclusion Criteria:

  • Female participants aged 18 years and older
  • Scheduled to undergo mammography and breast ultrasonography
  • Undergoing these imaging procedures for the first time
  • Literate (able to read and understand study materials)
  • No sensory or motor impairment affecting the upper extremities (hands/arms)
  • Willing to participate and able to provide written informed consent

Exclusion Criteria:

  • Previous experience of mammography or breast ultrasonography
  • Presence of any cognitive impairment that may affect understanding or communication
  • Presence of any physical disability that may interfere with participation
  • Hearing or visual impairment that may hinder communication or completion of study procedures
  • Refusal to participate or inability to provide informed consent

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Preventie
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Geen (open label)

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Stress Ball Intervention
Participants in this group will be provided with a soft, smooth stress ball (approximately 6 cm in diameter) before the imaging procedure. They will be instructed to rhythmically squeeze and relax the ball while waiting for the procedure and to continue its use during breast ultrasonography.
Participants will be provided with a soft, smooth stress ball (approximately 6 cm in diameter) prior to the imaging procedure. They will be instructed to rhythmically squeeze and release the ball while waiting for mammography and to continue using it during breast ultrasonography until the procedure is completed.
Experimenteel: Empathic Verbal Communication with Therapeutic Touch
Participants in this group will be guided to a quiet waiting area where trained researchers will deliver standardized empathic verbal statements. Simultaneously, gentle therapeutic touch will be applied by placing a hand on the participant's shoulder to provide reassurance and emotional support prior to the procedure.
Empathic Verbal Communication with Therapeutic Touch (Behavioral) Participants will be taken to a quiet waiting area before the procedure. Trained researchers will deliver standardized empathic verbal statements to provide reassurance and emotional support. At the same time, gentle therapeutic touch will be applied by placing a hand on the participant's shoulder. The intervention will be administered prior to the imaging procedure.
Geen tussenkomst: Control (Routine Care)
Participants in the control group will receive routine clinical care without any additional intervention beyond standard practice.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Anxiety Level
Tijdsspanne: Immediately before and immediately after mammography and breast ultrasonography (same day)
Anxiety levels will be assessed using the State-Trait Anxiety Inventory (STAI). Higher scores indicate higher levels of anxiety
Immediately before and immediately after mammography and breast ultrasonography (same day)
Pain Intensity
Tijdsspanne: Immediately after mammography and breast ultrasonography (same day)
Pain intensity will be evaluated using a Numerical Rating Scale (0-10), where 0 indicates no pain and 10 indicates the worst possible pain.
Immediately after mammography and breast ultrasonography (same day)

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Geschat)

4 mei 2026

Primaire voltooiing (Geschat)

14 september 2026

Studie voltooiing (Geschat)

30 september 2026

Studieregistratiedata

Eerst ingediend

25 april 2026

Eerst ingediend dat voldeed aan de QC-criteria

25 april 2026

Eerst geplaatst (Werkelijk)

1 mei 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

1 mei 2026

Laatste update ingediend die voldeed aan QC-criteria

25 april 2026

Laatst geverifieerd

1 april 2026

Meer informatie

Termen gerelateerd aan deze studie

Andere studie-ID-nummers

  • 2025/67

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren